Skip to main content

About us
About Blood Cancer United

Who we are

Financials

Leadership

DEI/Health equity commitment

Careers

Contact us
Featured programs

The Dare to Dream Project

Light The Night
Partners and suppliers

Corporate partnerships

Supplier resources
Stories and news

Our stories

Newsroom

Blog
Talk to Information Specialist +1-800-955-4572 (Monday–Friday 9 a.m.–9 p.m. ET)

Email Live Chat
Financial assistance
Financial support

Explore all assistance programs

Patient Aid Program

Co-Pay Assistance Program

Local Financial Assistance Program

Patient Travel Assistance Program

Pre-CAR T-cell Therapy Travel Assistance Program

Urgent Need Programs
Additional financial assistance

Scholarships for Blood Cancer Survivors

Veterans Dental Partnership

Other financial assistance
Claims

Track your claim
Talk to Information Specialist +1-800-955-4572 (Monday–Friday 9 a.m.–9 p.m. ET)

Email Live Chat
Advocacy
Policy and advocacy

Overview

What does the Office of Public Policy do?
Featured efforts

Making treatment affordable for patients

Improving the quality of health insurance

Making clinical trials work for patients

Cost of cancer care

Advocating for pediatric patients and survivors

Ensuring medicaid is available and stable

Accelerating progress in cancer R&D
Sign up now

Be an advocate

Join the Mobile Action Network
Talk to Information Specialist +1-800-955-4572 (Monday–Friday 9 a.m.–9 p.m. ET)

Email Live Chat
Local groups
Careers
En Español

Donate now 0 items in cart

Blood cancers

Types of blood cancer

Leukemia
Acute lymphoblastic leukemia (ALL) Acute myeloid leukemia (AML) Chronic lymphocytic leukemia (CLL) Chronic myeloid leukemia (CML) Hairy cell leukemia (HCL) Chronic myelomonocytic leukemia (CMML) Juvenile myelomonocytic leukemia (JMML) Large granular lymphocytic (LGL) leukemia Blastic plasmacytoid dendritic cell neoplasm (BPDCN) B-cell prolymphocytic leukemia (B-PLL) T-cell prolymphocytic leukemia (T-PLL)

Lymphoma
Non-Hodgkin lymphoma (NHL) Hodgkin lymphoma

Myeloma

Myelodysplastic syndromes (MDS)

Myeloproliferative neoplasms (MPNs)
Essential thrombocythemia (ET) Myelofibrosis (MF) Polycythemia vera (PV)

Blood cancer facts and statistics

Leukemia, lymphoma, myeloma, and myelodysplastic syndromes (MDS) are types of cancer that can affect the bone marrow, the blood cells, the lymph nodes, and other parts of the lymphatic system.

Talk to an Information Specialist +1-800-955-4572 (Monday–Friday 9 a.m.–9 p.m. ET)

Email Live Chat
Navigating your care

Navigate care by patient type

Adults
Working with your care team Treatment options Know your rights, manage your finances Managing daily life After treatment

Young adults
Working with your care team Treatment options Know your rights, manage your finances Managing daily life After treatment

Children and teens
Working with your child's care team Coping with a child's diagnosis Know your rights, manage your finances Caring for your child during treatment After treatment

Cancer drug listing

Find detailed information for nearly 200 cancer drugs, including brand and generic names for each drug, what it is intended to treat, how it is administered, and possible side effects.

Talk to an Information Specialist +1-800-955-4572 (Monday–Friday 9 a.m.–9 p.m. ET)

Email Live Chat
Resources

Resources

Patient resources

Caregiver resources

Healthcare professional resources

Educational resources
Publications Webcasts/Videos Blood cancer conferences 3D Model Library

Support resources
Information Specialists Clinical Trial Support Center (CTSC) Registered Dietitians Online chats Support groups Peer-to-peer support Podcasts Health Manager mobile app Registry Other helpful organizations

Newsroom
Blog Suggested reading

Talk to an Information Specialist +1-800-955-4572 (Monday–Friday 9 a.m.–9 p.m. ET)

Email Live Chat
Research

Research

Who we fund

Research we fund

Impact on research progress

Research Grant Programs

Therapy Acceleration Program® (TAP)

Beat AML®

Talk to an Information Specialist +1-800-955-4572 (Monday–Friday 9 a.m.–9 p.m. ET)

Email Live Chat
Get involved

Get involved

Policy and advocacy

Shop

College Campus Clubs

Ways to donate
Donor-advised funds Honor and memorial gifts Cryptocurrency Stock gifts Wills, annuities, and other planned gifts Employee Matching Gifts

Ways to volunteer
Volunteer Portal Volunteer Grants

Fundraising
Athletic Events America's Most Beautiful Bike Ride Big Climb Climb 2 Cure Light The Night Scenic Shore 150 Shred for Red Visionaries of the Year Student Visionaries of the Year Velo Palmetto

Talk to an Information Specialist +1-800-955-4572 (Monday–Friday 9 a.m.–9 p.m. ET)

Email Live Chat

Donate now

Search

Popular Keywords

Financial Assistance Leukemia Support Treatments Ways to Support

Talk to Information Specialist
+1-800-955-4572 (Monday–Friday 9 a.m.–9 p.m. ET)

Email Live Chat

Search Results

Filter Results

7070 results for

Refine Your Search

Nourishing the Pediatric Patient During Cancer Treatment

Nourishing the Pediatric Patient During Cancer Treatment

Non-Hodgkin Lymphoma: Know Your Subtype

Non-Hodgkin Lymphoma: Know Your Subtype

Navigating the Financial Maze for Cancer Survivorship

Navigating the Financial Maze for Cancer Survivorship

Navegando por la salud a largo plazo después del cáncer De la sangre en niños y adolescentes

Navegando por la salud a largo plazo después del cáncer De la sangre en niños y adolescentes

Matt

Meet Matt. Hodgkin Lymphoma Survivor. Goalkeeper of major league soccer's Columbus Crew. After donating blood when he was 17 years old, Matt learned h…

Update on Waldenström Macroglobulinemia (WM)

Update on Waldenström Macroglobulinemia (WM)

Treatment Update: Myelodysplastic Syndromes (MDS)

Treatment Update: Myelodysplastic Syndromes (MDS)

Empowering Myeloma Patients: Strategies For Managing Side Effects

Empowering Myeloma Patients: Strategies For Managing Side Effects

Highlights in Therapy: Multiple Myeloma

Highlights in Therapy: Multiple Myeloma

Spotlight On Multiple Myeloma

Spotlight On Multiple Myeloma

Understanding My Treatment Options: Multiple Myeloma

Understanding My Treatment Options: Multiple Myeloma

Advances in Multiple Myeloma

Advances in Multiple Myeloma

Acute Lymphoblastic Leukemia (ALL) In Children And Adults

Acute Lymphoblastic Leukemia (ALL) In Children And Adults

Advances in Acute Myeloid Leukemia

Advances in Acute Myeloid Leukemia

Advances in CAR T-Cell Therapy

Advances in CAR T-Cell Therapy

Advances in Chronic Myeloid Leukemia

Pediatric Blood Cancer Initiatives & Advances Regarding Bone Marrow/Stem Cell Transplant and CAR T-cell Therapy

Survivorship Series: Communicating with your Healthcare Team

Survivorship Series: Communicating with your Healthcare Team

Treating Aggressive Non-Hodgkin Lymphomas (NHL)

Treating Aggressive Non-Hodgkin Lymphomas (NHL)

Treatment Advances For Multiple Myeloma

Treatment Advances For Multiple Myeloma

Treatment Advances for Myelodysplastic Syndromes (MDS)

Treatment Advances for Myelodysplastic Syndromes (MDS)

Treatment Advances For Slow-Growing Non-Hodgkin Lymphomas

Treatment Advances For Slow-Growing Non-Hodgkin Lymphomas

Advances in Treating Myeloproliferative Neoplasms

Advances in Treating Myeloproliferative Neoplasms

Treatment Updates: Multiple Myeloma

Treatment Updates: Multiple Myeloma

Advances in Treatment for Chronic Lymphocytic Leukemia (CLL)

Advances in Treatment for Chronic Lymphocytic Leukemia (CLL)

Previous page
page 1
...
Page 6
Current page 7
Page 8
...
page 283
Next

Previous
Next

Refine your search

Sort by

Disease Type

Leukemia (829)

Lymphoma (680)

Myeloma (456)

Acute Myeloid Leukemia (AML) (357)

Acute Lymphoblastic Leukemia (ALL) (311)

Other Blood Cancers (262)

Non-Hodgkin Lymphoma (NHL) (241)

Myelodysplastic Syndromes (MDS) (229)

Hodgkin Lymphoma (HL) (224)

Myeloproliferative Neoplasms (MPN) (201)

Chronic Lymphocytic Leukemia (CLL/SLL) (94)

Chronic Myeloid Leukemia (CML) (86)

Diffuse Large B-cell Lymphoma (DLBCL) (54)

Juvenile Myelomonocytic Leukemia (JMML) (49)

Follicular Lymphoma (FL) (42)

Mantle Cell Lymphoma (MCL) (35)

Hairy Cell Leukemia (HCL) (27)

Acute promyelocytic leukemia (APL) (23)

Polycythemia Vera (23)

Chronic Myelomonocytic Leukemia (CMML) (22)

Primary Myelofibrosis (21)

Waldenström Macroglobulinemia (WM) (21)

Essential Thrombocythemia (18)

Chronic Lymphocytic Leukemia/Small-cell Lymphocytic Lymphoma (CLL/SLL) (16)

Burkitt Lymphoma (BL) (15)

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) (12)

Marginal Zone Lymphoma (MZL) (12)

Large B-Cell Lymphoma (LBCL) (11)

Myeloma-related Amyloidosis (11)

Adult T-cell Leukemia/Lymphoma (10)

T-Cell Prolymphocytic Leukemia (10)

Cutaneous T-cell Lymphoma (CTCL) (9)

Peripheral T-cell Lymphoma, Not Otherwise Specified (PTCL-NOS) (9)

B-Cell Prolymphocytic Leukemia (8)

Large Granular Lymphocytic Leukemia (LGL) (8)

Plasma Cell Leukemia (8)

Chronic Eosinophilic Leukemia (7)

POEMS Syndrome (7)

High-grade B-cell Lymphoma with double or triple hits (HBL) (6)

Angioimmunoblastic T-cell Lymphoma (AITL) (5)

Lymphoblastic Lymphoma (5)

Primary Mediastinal (Thymic) Large B-cell Lymphoma (PMBCL) (5)

MDS Primary (4)

MPAL (4)

Nodal Marginal Zone Lymphoma (NMZL) (4)

Primary Central Nervous System (CNS) Lymphoma (4)

Systemic Anaplastic Large-cell Lymphoma (ALCL) (4)

Acquired Immunodeficiency Syndrome (AIDS)-associated Lymphoma (3)

Chronic Neutrophilic Leukemia (3)

Enteropathy-associated Intestinal T-cell Lymphoma (3)

Extranodal Natural Killer (NK)/T-cell Lymphoma (ENK/TCL), nasal type (3)

Gastric Mucosa-associated Lymphoid Tissue (MALT) Lymphoma (3)

Hepatosplenic T-cell Lymphoma (3)

MD Secondary (3)

Primary Cutaneous Anaplastic Large-cell Lymphoma (pcALCL) (3)

Primary Cutaneous DLBCL, leg type (3)

Primary DLBCL of the central nervous system (3)

Prolymphocytic Leukemia (3)

Splenic Marginal Zone Lymphoma (SMZL) (3)

Subcutaneous Panniculitis-like T-cell Lymphoma (SPTCL) (3)

Transformed Follicular and Transformed Mucosa-associated Lymphoid Tissue (MALT) Lymphomas (3)

Lymphoplasmacytic Lymphoma (2)

MDS/MDP Overlap (2)

Constituent Type

All Audiences (332)

Patient: Adult (173)

Caregiver (162)

Patient: Young Adults (161)

Adults (127)

Patient: Children and Teens (126)

Research (59)

Teens & Children (51)

Young Adult (32)

Policy/Advocate (29)

Healthcare Professional (15)

Donor/Fundraiser (10)

Partner (3)

Sponsor (3)

Volunteer (3)

LGBTQIA+ (2)

Other (1)

Other Organizations (1)

Media type

Event (1781)

Article (1290)

Inspirational Stories (1009)

Grant (413)

Partner Organization (379)

Support Resource (350)

Booklet (313)

Mission (309)

Grant Recipient (295)

Video (173)

Drug (165)

Suggested reading (147)

Blog (140)

Landing Page (118)

Basic Page (112)

Marketing Page (73)

Financial Assistance Program (3)

Popular Keywords

The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United. Learn more.

Get connected, stay informed

Call an Information Specialist

Highly trained oncology social workers and nurses.

+1-800-955-4572

(Monday–Friday 9 a.m.–9 p.m. ET)

Live chat | Email

Donate

Your donation supports groundbreaking research and vital patient services.

+1-888-557-7177

(Monday–Friday 9:30 a.m.–5:00 p.m. ET)

More ways to give.

Contact us
Privacy Policy (PDF*)
Consumer Health Data Privacy Policy (PDF*)
Security (PDF*)
Copyright (PDF*)
Link Policy (PDF*)
Website terms of use (PDF*)
Financial transparency and independence (PDF*)
Fundraising disclosure (PDF*)
Refund Policy (PDF*)
Community guidelines (PDF*)
Accessibility statement (PDF*)
LLS Canada
^{*Bilingual content/Contenido bilingüe}

Follow us

The Blood Cancer United mission: Cure blood cancer and improve the quality of life of all patients and their families. Blood Cancer United funds lifesaving blood cancer research around the world, provides free information and support services, and is the voice for all blood cancer patients seeking access to quality, affordable, coordinated care.

Blood Cancer United is a 501(c)(3) organization, and all monetary donations are tax deductible to the fullest extent allowed by tax laws. Please check with your financial advisor if you have more questions. Tax Identification Number: 13-5644916

© Copyright 2015-2025 Blood Cancer United. A 501(c)(3) organization. All rights reserved.